Institutional investors purchased a net $312.3 thousand shares of LMNX during the quarter ended December 2012, and now own 72.94% of the total float, a percentage that is typical for companies in the Biotechnology industry.
| Mutual fund holders | 42.39% |
| Other institutional | 30.55% |
| Individual stakeholders | 12.87% |